InvestorsHub Logo
Followers 0
Posts 110
Boards Moderated 0
Alias Born 03/08/2017

Re: None

Monday, 03/20/2017 8:27:38 PM

Monday, March 20, 2017 8:27:38 PM

Post# of 234
Folks who are new to OCUL and may not know. Here are the details on partnership with REGN. REGN is at $382/sh and more than $1B cash

https://www.streetinsider.com/dr/news.php?id=12128415

Besides Dextenza, there is sNDA for new indication. Glaucoma trials are positive so far!!!! Massive undervalued play $$$$$
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent OCUL News